Publication Results

Generate Report

Add publications by marking their checkboxes, or

Tobacco, alcohol, body mass index, physical activity, and the risk of head and neck cancer in the prostate, lung, colorectal, and ovarian (PLCO) cohort.

Hashibe M,  Hunt J,  Wei M,  Buys S,  Gren L,  Lee YC
Head Neck 2013 Jul;35(7):914-22
PubMed ID: 22711227
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Who should be included in a clinical trial of screening for bladder cancer?: a decision analysis of data from the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.

Vickers AJ,  Bennette C,  Kibel AS,  Black A,  Izmirlian G,  Stephenson AJ,  Bochner B
Cancer 2013 Jan 1;119(1):143-9
PubMed ID: 22736219
PMC ID: PMC4036636
Groups or Programs: Early DetectionBiometryPLCO Cancer Screening Trial

Non-steroidal anti-inflammatory drug use and the risk of benign prostatic hyperplasia-related outcomes and nocturia in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.

Sutcliffe S,  Grubb Iii RL,  Platz EA,  Ragard LR,  Riley TL,  Kazin SS,  Hayes RB,  Hsing AW,  Andriole GL,  Urologic Diseases in America Project
BJU Int 2012 Oct;110(7):1050-9
PubMed ID: 22429766
PMC ID: PMC3382045
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Long-term disease-specific functioning among prostate cancer survivors and noncancer controls in the prostate, lung, colorectal, and ovarian cancer screening trial.

Taylor KL,  Luta G,  Miller AB,  Church TR,  Kelly SP,  Muenz LR,  Davis KM,  Dawson DL,  Edmond S,  Reding D,  Mabie JE,  Riley TL
J Clin Oncol 2012 Aug 1;30(22):2768-75
PubMed ID: 22734029
PMC ID: PMC4166119
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Factors associated with inadequate colorectal cancer screening with flexible sigmoidoscopy.

Laiyemo AO,  Doubeni C,  Pinsky PF,  Doria-Rose VP,  Sanderson AK 2nd,  Bresalier R,  Weissfeld J,  Schoen RE,  Marcus PM,  Prorok PC,  Berg CD
Cancer Epidemiol 2012 Aug;36(4):395-9
PubMed ID: 22112544
PMC ID: PMC3288883
Groups or Programs: Early DetectionBiometryPLCO Cancer Screening Trial

Serum IGF1, IGF2 and IGFBP3 and risk of advanced colorectal adenoma.

Gao Y,  Katki H,  Graubard B,  Pollak M,  Martin M,  Tao Y,  Schoen RE,  Church T,  Hayes RB,  Greene MH,  Berndt SI
Int J Cancer 2012 Jul 15;131(2):E105-13
PubMed ID: 21932422
PMC ID: PMC3288254
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Assessing disease risk in genome-wide association studies using family history.

Ghosh A,  Hartge P,  Purdue MP,  Chanock SJ,  Amundadottir L,  Wang Z,  Wentzensen N,  Chatterjee N,  Wacholder S
Epidemiology 2012 Jul;23(4):616-22
PubMed ID: 22575968
PMC ID: PMC3371359
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Tracking and tracing of participants in two large cancer screening trials.

Marcus PM,  Childs J,  Gahagan B,  Gren LH
Contemp Clin Trials 2012 Jul;33(4):601-5
PubMed ID: 22561392
PMC ID: PMC3361574
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Serum vitamin D and risk of bladder cancer in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening trial.

Mondul AM,  Weinstein SJ,  Horst RL,  Purdue M,  Albanes D
Cancer Epidemiol Biomarkers Prev 2012 Jul;21(7):1222-5
PubMed ID: 22623707
PMC ID: PMC3392360
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Aspirin but not ibuprofen use is associated with reduced risk of prostate cancer: a PLCO study.

Shebl FM,  Sakoda LC,  Black A,  Koshiol J,  Andriole GL,  Grubb R,  Church TR,  Chia D,  Zhou C,  Chu LW,  Huang WY,  Peters U,  Kirsh VA,  Chatterjee N,  Leitzmann MF,  Hayes RB,  Hsing AW
Br J Cancer 2012 Jun 26;107(1):207-14
PubMed ID: 22722313
PMC ID: PMC3389420
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Alcohol, genetics and risk of breast cancer in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.

McCarty CA,  Reding DJ,  Commins J,  Williams C,  Yeager M,  Burmester JK,  Schairer C,  Ziegler RG
Breast Cancer Res Treat 2012 Jun;133(2):785-92
PubMed ID: 22331481
PMC ID: PMC3584637
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Characterization of gene-environment interactions for colorectal cancer susceptibility loci.

Hutter CM,  Chang-Claude J,  Slattery ML,  Pflugeisen BM,  Lin Y,  Duggan D,  Nan H,  Lemire M,  Rangrej J,  Figueiredo JC,  Jiao S,  Harrison TA,  Liu Y,  Chen LS,  Stelling DL,  Warnick GS,  Hoffmeister M,  Küry S,  Fuchs CS,  Giovannucci E,  Hazra A,  Kraft P,  Hunter DJ,  Gallinger S,  Zanke BW,  Brenner H,  Frank B,  Ma J,  Ulrich CM,  White E,  Newcomb PA,  Kooperberg C,  LaCroix AZ,  Prentice RL,  Jackson RD,  Schoen RE,  Chanock SJ,  Berndt SI,  Hayes RB,  Caan BJ,  Potter JD,  Hsu L,  Bézieau S,  Chan AT,  Hudson TJ,  Peters U
Cancer Res 2012 Apr 15;72(8):2036-44
PubMed ID: 22367214
PMC ID: PMC3374720
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Longitudinal evaluation of CA-125 velocity and prediction of ovarian cancer.

Xu JL,  Commins J,  Partridge E,  Riley TL,  Prorok PC,  Johnson CC,  Buys SS
Gynecol Oncol 2012 Apr;125(1):70-4
PubMed ID: 22198243
PMC ID: PMC3303942
Groups or Programs: Early DetectionBiometryPLCO Cancer Screening Trial

Associations between genes in the one-carbon metabolism pathway and advanced colorectal adenoma risk in individuals with low folate intake.

Han SS,  Sue LY,  Berndt SI,  Selhub J,  Burdette LA,  Rosenberg PS,  Ziegler RG
Cancer Epidemiol Biomarkers Prev 2012 Mar;21(3):417-27
PubMed ID: 22253295
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Fine mapping of 14q24.1 breast cancer susceptibility locus.

Lee P,  Fu YP,  Figueroa JD,  Prokunina-Olsson L,  Gonzalez-Bosquet J,  Kraft P,  Wang Z,  Jacobs KB,  Yeager M,  Horner MJ,  Hankinson SE,  Hutchinson A,  Chatterjee N,  Garcia-Closas M,  Ziegler RG,  Berg CD,  Buys SS,  McCarty CA,  Feigelson HS,  Thun MJ,  Diver R,  Prentice R,  Jackson R,  Kooperberg C,  Chlebowski R,  Lissowska J,  Peplonska B,  Brinton LA,  Tucker M,  Fraumeni JF Jr,  Hoover RN,  Thomas G,  Hunter DJ,  Chanock SJ
Hum Genet 2012 Mar;131(3):479-90
PubMed ID: 21959381
PMC ID: PMC4159746
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Colorectal cancers not detected by screening flexible sigmoidoscopy in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.

Schoen RE,  Pinsky PF,  Weissfeld JL,  Yokochi LA,  Church T,  Laiyemo AO,  Bresalier R,  Hickey T,  Riley T,  Prorok PC
Gastrointest Endosc 2012 Mar;75(3):612-20
PubMed ID: 22341106
PMC ID: not available
Groups or Programs: Early DetectionBiometryPLCO Cancer Screening Trial

Estrogen metabolism and risk of breast cancer in postmenopausal women.

Fuhrman BJ,  Schairer C,  Gail MH,  Boyd-Morin J,  Xu X,  Sue LY,  Buys SS,  Isaacs C,  Keefer LK,  Veenstra TD,  Berg CD,  Hoover RN,  Ziegler RG
J Natl Cancer Inst 2012 Feb 22;104(4):326-39
PubMed ID: 22232133
PMC ID: PMC3283536
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Flexible sigmoidoscopy in the randomized prostate, lung, colorectal, and ovarian (PLCO) cancer screening trial: added yield from a second screening examination.

Weissfeld JL,  Schoen RE,  Pinsky PF,  Bresalier RS,  Doria-Rose VP,  Laiyemo AO,  Church T,  Yokochi LA,  Yurgalevitch S,  Rathmell J,  Andriole GL,  Buys S,  Crawford ED,  Fouad M,  Isaacs C,  Lamerato L,  Reding D,  Prorok PC,  Berg CD,  PLCO Project Team
J Natl Cancer Inst 2012 Feb 22;104(4):280-9
PubMed ID: 22298838
PMC ID: PMC3283538
Groups or Programs: Early DetectionBiometryPLCO Cancer Screening Trial

Meta-analysis of new genome-wide association studies of colorectal cancer risk.

Peters U,  Hutter CM,  Hsu L,  Schumacher FR,  Conti DV,  Carlson CS,  Edlund CK,  Haile RW,  Gallinger S,  Zanke BW,  Lemire M,  Rangrej J,  Vijayaraghavan R,  Chan AT,  Hazra A,  Hunter DJ,  Ma J,  Fuchs CS,  Giovannucci EL,  Kraft P,  Liu Y,  Chen L,  Jiao S,  Makar KW,  Taverna D,  Gruber SB,  Rennert G,  Moreno V,  Ulrich CM,  Woods MO,  Green RC,  Parfrey PS,  Prentice RL,  Kooperberg C,  Jackson RD,  Lacroix AZ,  Caan BJ,  Hayes RB,  Berndt SI,  Chanock SJ,  Schoen RE,  Chang-Claude J,  Hoffmeister M,  Brenner H,  Frank B,  Bézieau S,  Küry S,  Slattery ML,  Hopper JL,  Jenkins MA,  Le Marchand L,  Lindor NM,  Newcomb PA,  Seminara D,  Hudson TJ,  Duggan DJ,  Potter JD,  Casey G
Hum Genet 2012 Feb;131(2):217-34
PubMed ID: 21761138
PMC ID: PMC3257356
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up.

Andriole GL,  Crawford ED,  Grubb RL 3rd,  Buys SS,  Chia D,  Church TR,  Fouad MN,  Isaacs C,  Kvale PA,  Reding DJ,  Weissfeld JL,  Yokochi LA,  O'Brien B,  Ragard LR,  Clapp JD,  Rathmell JM,  Riley TL,  Hsing AW,  Izmirlian G,  Pinsky PF,  Kramer BS,  Miller AB,  Gohagan JK,  Prorok PC,  PLCO Project Team
J Natl Cancer Inst 2012 Jan 18;104(2):125-32
PubMed ID: 22228146
PMC ID: PMC3260132
Groups or Programs: Early DetectionBiometryPLCO Cancer Screening Trial

Proteomic biomarkers in combination with CA 125 for detection of epithelial ovarian cancer using prediagnostic serum samples from the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.

Moore LE,  Pfeiffer RM,  Zhang Z,  Lu KH,  Fung ET,  Bast RC Jr
Cancer 2012 Jan 1;118(1):91-100
PubMed ID: 21717433
PMC ID: PMC3385508
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Pancreatic cancer risk: associations with meat-derived carcinogen intake in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO) cohort.

Anderson KE,  Mongin SJ,  Sinha R,  Stolzenberg-Solomon R,  Gross MD,  Ziegler RG,  Mabie JE,  Risch A,  Kazin SS,  Church TR
Mol Carcinog 2012 Jan;51(1):128-37
PubMed ID: 22162237
PMC ID: PMC3516181
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

The association between inflammation-related genes and serum androgen levels in men: the prostate, lung, colorectal, and ovarian study.

Meyer TE,  Chu LW,  Li Q,  Yu K,  Rosenberg PS,  Menashe I,  Chokkalingam AP,  Quraishi SM,  Huang WY,  Weiss JM,  Kaaks R,  Hayes RB,  Chanock SJ,  Hsing AW
Prostate 2012 Jan;72(1):65-71
PubMed ID: 21520164
PMC ID: PMC3156884
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Serum α-tocopherol and γ-tocopherol concentrations and prostate cancer risk in the PLCO Screening Trial: a nested case-control study.

Weinstein SJ,  Peters U,  Ahn J,  Friesen MD,  Riboli E,  Hayes RB,  Albanes D
PLoS One 2012;7(7):e40204
PubMed ID: 22792240
PMC ID: PMC3390343
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

N-acetyltransferase 2 polymorphisms, tobacco smoking, and breast cancer risk in the breast and prostate cancer cohort consortium.

Cox DG,  Dostal L,  Hunter DJ,  Le Marchand L,  Hoover R,  Ziegler RG,  Thun MJ,  Breast and Prostate Cancer Cohort Consortium
Am J Epidemiol 2011 Dec 1;174(11):1316-22
PubMed ID: 22074863
PMC ID: PMC3390163
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Genome-wide association study of circulating retinol levels.

Mondul AM,  Yu K,  Wheeler W,  Zhang H,  Weinstein SJ,  Major JM,  Cornelis MC,  Männistö S,  Hazra A,  Hsing AW,  Jacobs KB,  Eliassen H,  Tanaka T,  Reding DJ,  Hendrickson S,  Ferrucci L,  Virtamo J,  Hunter DJ,  Chanock SJ,  Kraft P,  Albanes D
Hum Mol Genet 2011 Dec 1;20(23):4724-31
PubMed ID: 21878437
PMC ID: PMC3209826
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Prostate-specific antigen 1.5-4.0 ng/mL: a diagnostic challenge and danger zone.

Crawford ED,  Moul JW,  Rove KO,  Pettaway CA,  Lamerato LE,  Hughes A
BJU Int 2011 Dec;108(11):1743-9
PubMed ID: 21711431
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Screening by chest radiograph and lung cancer mortality: the Prostate, Lung, Colorectal, and Ovarian (PLCO) randomized trial.

Oken MM,  Hocking WG,  Kvale PA,  Andriole GL,  Buys SS,  Church TR,  Crawford ED,  Fouad MN,  Isaacs C,  Reding DJ,  Weissfeld JL,  Yokochi LA,  O'Brien B,  Ragard LR,  Rathmell JM,  Riley TL,  Wright P,  Caparaso N,  Hu P,  Izmirlian G,  Pinsky PF,  Prorok PC,  Kramer BS,  Miller AB,  Gohagan JK,  Berg CD,  PLCO Project Team
JAMA 2011 Nov 2;306(17):1865-73
PubMed ID: 22031728
PMC ID: not available
Groups or Programs: Early DetectionBiometryPLCO Cancer Screening Trial

Potential role of HE4 in multimodal screening for epithelial ovarian cancer.

Urban N,  Thorpe JD,  Bergan LA,  Forrest RM,  Kampani AV,  Scholler N,  O'Briant KC,  Anderson GL,  Cramer DW,  Berg CD,  McIntosh MW,  Hartge P,  Drescher CW
J Natl Cancer Inst 2011 Nov 2;103(21):1630-4
PubMed ID: 21917606
PMC ID: PMC3206037
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Intra-individual variability over time in serum cytokine levels among participants in the prostate, lung, colorectal, and ovarian cancer screening Trial.

Hofmann JN,  Yu K,  Bagni RK,  Lan Q,  Rothman N,  Purdue MP
Cytokine 2011 Nov;56(2):145-8
PubMed ID: 21764327
PMC ID: PMC3185107
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

The use of imputed values in the meta-analysis of genome-wide association studies.

Jiao S,  Hsu L,  Hutter CM,  Peters U
Genet Epidemiol 2011 Nov;35(7):597-605
PubMed ID: 21769935
PMC ID: PMC3201718
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Genome-wide association study identifies new prostate cancer susceptibility loci.

Schumacher FR,  Berndt SI,  Siddiq A,  Jacobs KB,  Wang Z,  Lindstrom S,  Stevens VL,  Chen C,  Mondul AM,  Travis RC,  Stram DO,  Eeles RA,  Easton DF,  Giles G,  Hopper JL,  Neal DE,  Hamdy FC,  Donovan JL,  Muir K,  Al Olama AA,  Kote-Jarai Z,  Guy M,  Severi G,  Grönberg H,  Isaacs WB,  Karlsson R,  Wiklund F,  Xu J,  Allen NE,  Andriole GL,  Barricarte A,  Boeing H,  Bueno-de-Mesquita HB,  Crawford ED,  Diver WR,  Gonzalez CA,  Gaziano JM,  Giovannucci EL,  Johansson M,  Le Marchand L,  Ma J,  Sieri S,  Stattin P,  Stampfer MJ,  Tjonneland A,  Vineis P,  Virtamo J,  Vogel U,  Weinstein SJ,  Yeager M,  Thun MJ,  Kolonel LN,  Henderson BE,  Albanes D,  Hayes RB,  Feigelson HS,  Riboli E,  Hunter DJ,  Chanock SJ,  Haiman CA,  Kraft P
Hum Mol Genet 2011 Oct 1;20(19):3867-75
PubMed ID: 21743057
PMC ID: PMC3168287
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Identification, replication, and fine-mapping of Loci associated with adult height in individuals of african ancestry.

N'Diaye A,  Chen GK,  Palmer CD,  Ge B,  Tayo B,  Mathias RA,  Ding J,  Nalls MA,  Adeyemo A,  Adoue V,  Ambrosone CB,  Atwood L,  Bandera EV,  Becker LC,  Berndt SI,  Bernstein L,  Blot WJ,  Boerwinkle E,  Britton A,  Casey G,  Chanock SJ,  Demerath E,  Deming SL,  Diver WR,  Fox C,  Harris TB,  Hernandez DG,  Hu JJ,  Ingles SA,  John EM,  Johnson C,  Keating B,  Kittles RA,  Kolonel LN,  Kritchevsky SB,  Le Marchand L,  Lohman K,  Liu J,  Millikan RC,  Murphy A,  Musani S,  Neslund-Dudas C,  North KE,  Nyante S,  Ogunniyi A,  Ostrander EA,  Papanicolaou G,  Patel S,  Pettaway CA,  Press MF,  Redline S,  Rodriguez-Gil JL,  Rotimi C,  Rybicki BA,  Salako B,  Schreiner PJ,  Signorello LB,  Singleton AB,  Stanford JL,  Stram AH,  Stram DO,  Strom SS,  Suktitipat B,  Thun MJ,  Witte JS,  Yanek LR,  Ziegler RG,  Zheng W,  Zhu X,  Zmuda JM,  Zonderman AB,  Evans MK,  Liu Y,  Becker DM,  Cooper RS,  Pastinen T,  Henderson BE,  Hirschhorn JN,  Lettre G,  Haiman CA
PLoS Genet 2011 Oct;7(10):e1002298
PubMed ID: 21998595
PMC ID: PMC3188544
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Circulating markers of interstitial lung disease and subsequent risk of lung cancer.

Shiels MS,  Chaturvedi AK,  Katki HA,  Gochuico BR,  Caporaso NE,  Engels EA
Cancer Epidemiol Biomarkers Prev 2011 Oct;20(10):2262-72
PubMed ID: 21828236
PMC ID: PMC3189337
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Iron homeostasis and distal colorectal adenoma risk in the prostate, lung, colorectal, and ovarian cancer screening trial.

Cross AJ,  Sinha R,  Wood RJ,  Xue X,  Huang WY,  Yeager M,  Hayes RB,  Gunter MJ
Cancer Prev Res (Phila) 2011 Sep;4(9):1465-75
PubMed ID: 21685236
PMC ID: PMC3168068
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Interactions between genetic variants and breast cancer risk factors in the breast and prostate cancer cohort consortium.

Campa D,  Kaaks R,  Le Marchand L,  Haiman CA,  Travis RC,  Berg CD,  Buring JE,  Chanock SJ,  Diver WR,  Dostal L,  Fournier A,  Hankinson SE,  Henderson BE,  Hoover RN,  Isaacs C,  Johansson M,  Kolonel LN,  Kraft P,  Lee IM,  McCarty CA,  Overvad K,  Panico S,  Peeters PH,  Riboli E,  Sanchez MJ,  Schumacher FR,  Skeie G,  Stram DO,  Thun MJ,  Trichopoulos D,  Zhang S,  Ziegler RG,  Hunter DJ,  Lindström S,  Canzian F
J Natl Cancer Inst 2011 Aug 17;103(16):1252-63
PubMed ID: 21791674
PMC ID: PMC3156803
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Large-scale fine mapping of the HNF1B locus and prostate cancer risk.

Berndt SI,  Sampson J,  Yeager M,  Jacobs KB,  Wang Z,  Hutchinson A,  Chung C,  Orr N,  Wacholder S,  Chatterjee N,  Yu K,  Kraft P,  Feigelson HS,  Thun MJ,  Diver WR,  Albanes D,  Virtamo J,  Weinstein S,  Schumacher FR,  Cancel-Tassin G,  Cussenot O,  Valeri A,  Andriole GL,  Crawford ED,  Haiman C,  Henderson B,  Kolonel L,  Le Marchand L,  Siddiq A,  Riboli E,  Travis RC,  Kaaks R,  Isaacs W,  Isaacs S,  Wiley KE,  Gronberg H,  Wiklund F,  Stattin P,  Xu J,  Zheng SL,  Sun J,  Vatten LJ,  Hveem K,  Njølstad I,  Gerhard DS,  Tucker M,  Hayes RB,  Hoover RN,  Fraumeni JF Jr,  Hunter DJ,  Thomas G,  Chanock SJ
Hum Mol Genet 2011 Aug 15;20(16):3322-9
PubMed ID: 21576123
PMC ID: PMC3140817
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Diabetes prevalence is associated with serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D in US middle-aged Caucasian men and women: a cross-sectional analysis within the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.

Brock KE,  Huang WY,  Fraser DR,  Ke L,  Tseng M,  Mason RS,  Stolzenberg-Solomon RZ,  Freedman DM,  Ahn J,  Peters U,  McCarty C,  Hollis BW,  Ziegler RG,  Purdue MP,  Graubard BI
Br J Nutr 2011 Aug;106(3):339-44
PubMed ID: 21736838
PMC ID: PMC3515777
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Likelihood of missed and recurrent adenomas in the proximal versus the distal colon.

Laiyemo AO,  Doubeni C,  Sanderson AK 2nd,  Pinsky PF,  Badurdeen DS,  Doria-Rose VP,  Marcus PM,  Schoen RE,  Lanza E,  Schatzkin A,  Cross AJ
Gastrointest Endosc 2011 Aug;74(2):253-61
PubMed ID: 21549375
PMC ID: PMC3148340
Groups or Programs: Early DetectionBiometryPLCO Cancer Screening Trial

The landscape of recombination in African Americans.

Hinch AG,  Tandon A,  Patterson N,  Song Y,  Rohland N,  Palmer CD,  Chen GK,  Wang K,  Buxbaum SG,  Akylbekova EL,  Aldrich MC,  Ambrosone CB,  Amos C,  Bandera EV,  Berndt SI,  Bernstein L,  Blot WJ,  Bock CH,  Boerwinkle E,  Cai Q,  Caporaso N,  Casey G,  Cupples LA,  Deming SL,  Diver WR,  Divers J,  Fornage M,  Gillanders EM,  Glessner J,  Harris CC,  Hu JJ,  Ingles SA,  Isaacs W,  John EM,  Kao WH,  Keating B,  Kittles RA,  Kolonel LN,  Larkin E,  Le Marchand L,  McNeill LH,  Millikan RC,  Murphy A,  Musani S,  Neslund-Dudas C,  Nyante S,  Papanicolaou GJ,  Press MF,  Psaty BM,  Reiner AP,  Rich SS,  Rodriguez-Gil JL,  Rotter JI,  Rybicki BA,  Schwartz AG,  Signorello LB,  Spitz M,  Strom SS,  Thun MJ,  Tucker MA,  Wang Z,  Wiencke JK,  Witte JS,  Wrensch M,  Wu X,  Yamamura Y,  Zanetti KA,  Zheng W,  Ziegler RG,  Zhu X,  Redline S,  Hirschhorn JN,  Henderson BE,  Taylor HA Jr,  Price AL,  Hakonarson H,  Chanock SJ,  Haiman CA,  Wilson JG,  Reich D,  Myers SR
Nature 2011 Jul 20;476(7359):170-5
PubMed ID: 21775986
PMC ID: PMC3154982
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Increased levels of circulating interleukin 6, interleukin 8, C-reactive protein, and risk of lung cancer.

Pine SR,  Mechanic LE,  Enewold L,  Chaturvedi AK,  Katki HA,  Zheng YL,  Bowman ED,  Engels EA,  Caporaso NE,  Harris CC
J Natl Cancer Inst 2011 Jul 20;103(14):1112-22
PubMed ID: 21685357
PMC ID: PMC3139587
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Prediagnostic serum levels of cytokines and other immune markers and risk of non-hodgkin lymphoma.

Purdue MP,  Lan Q,  Bagni R,  Hocking WG,  Baris D,  Reding DJ,  Rothman N
Cancer Res 2011 Jul 15;71(14):4898-907
PubMed ID: 21632552
PMC ID: PMC3138883
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study.

Kote-Jarai Z,  Olama AA,  Giles GG,  Severi G,  Schleutker J,  Weischer M,  Campa D,  Riboli E,  Key T,  Gronberg H,  Hunter DJ,  Kraft P,  Thun MJ,  Ingles S,  Chanock S,  Albanes D,  Hayes RB,  Neal DE,  Hamdy FC,  Donovan JL,  Pharoah P,  Schumacher F,  Henderson BE,  Stanford JL,  Ostrander EA,  Sorensen KD,  Dörk T,  Andriole G,  Dickinson JL,  Cybulski C,  Lubinski J,  Spurdle A,  Clements JA,  Chambers S,  Aitken J,  Gardiner RA,  Thibodeau SN,  Schaid D,  John EM,  Maier C,  Vogel W,  Cooney KA,  Park JY,  Cannon-Albright L,  Brenner H,  Habuchi T,  Zhang HW,  Lu YJ,  Kaneva R,  Muir K,  Benlloch S,  Leongamornlert DA,  Saunders EJ,  Tymrakiewicz M,  Mahmud N,  Guy M,  O'Brien LT,  Wilkinson RA,  Hall AL,  Sawyer EJ,  Dadaev T,  Morrison J,  Dearnaley DP,  Horwich A,  Huddart RA,  Khoo VS,  Parker CC,  Van As N,  Woodhouse CJ,  Thompson A,  Christmas T,  Ogden C,  Cooper CS,  Lophatonanon A,  Southey MC,  Hopper JL,  English DR,  Wahlfors T,  Tammela TL,  Klarskov P,  Nordestgaard BG,  Røder MA,  Tybjærg-Hansen A,  Bojesen SE,  Travis R,  Canzian F,  Kaaks R,  Wiklund F,  Aly M,  Lindstrom S,  Diver WR,  Gapstur S,  Stern MC,  Corral R,  Virtamo J,  Cox A,  Haiman CA,  Le Marchand L,  Fitzgerald L,  Kolb S,  Kwon EM,  Karyadi DM,  Orntoft TF,  Borre M,  Meyer A,  Serth J,  Yeager M,  Berndt SI,  Marthick JR,  Patterson B,  Wokolorczyk D,  Batra J,  Lose F,  McDonnell SK,  Joshi AD,  Shahabi A,  Rinckleb AE,  Ray A,  Sellers TA,  Lin HY,  Stephenson RA,  Farnham J,  Muller H,  Rothenbacher D,  Tsuchiya N,  Narita S,  Cao GW,  Slavov C,  Mitev V,  Easton DF,  Eeles RA,  UK Genetic Prostate Cancer Study Collaborators/British Association of Urological Surgeons' Section of Oncology,  UK ProtecT Study Collaborators, The Australian Prostate Cancer BioResource,  PRACTICAL Consortium
Nat Genet 2011 Jul 10;43(8):785-91
PubMed ID: 21743467
PMC ID: PMC3396006
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Lung cancer risk prediction: Prostate, Lung, Colorectal And Ovarian Cancer Screening Trial models and validation.

Tammemagi CM,  Pinsky PF,  Caporaso NE,  Kvale PA,  Hocking WG,  Church TR,  Riley TL,  Commins J,  Oken MM,  Berg CD,  Prorok PC
J Natl Cancer Inst 2011 Jul 6;103(13):1058-68
PubMed ID: 21606442
PMC ID: PMC3131220
Groups or Programs: Early DetectionBiometryPLCO Cancer Screening Trial

Dietary carbohydrate, glycemic index, glycemic load, and risk of prostate cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO) cohort.

Shikany JM,  Flood AP,  Kitahara CM,  Hsing AW,  Meyer TE,  Willcox BJ,  Redden DT,  Ziegler RG
Cancer Causes Control 2011 Jul;22(7):995-1002
PubMed ID: 21553078
PMC ID: PMC4470253
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial.

Buys SS,  Partridge E,  Black A,  Johnson CC,  Lamerato L,  Isaacs C,  Reding DJ,  Greenlee RT,  Yokochi LA,  Kessel B,  Crawford ED,  Church TR,  Andriole GL,  Weissfeld JL,  Fouad MN,  Chia D,  O'Brien B,  Ragard LR,  Clapp JD,  Rathmell JM,  Riley TL,  Hartge P,  Pinsky PF,  Zhu CS,  Izmirlian G,  Kramer BS,  Miller AB,  Xu JL,  Prorok PC,  Gohagan JK,  Berg CD,  PLCO Project Team
JAMA 2011 Jun 8;305(22):2295-303
PubMed ID: 21642681
PMC ID: not available
Groups or Programs: Early DetectionBiometryPLCO Cancer Screening Trial

The Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial: the prostate cancer screening results in context.

Berg CD
Acta Oncol 2011 Jun;50 Suppl 1:12-7
PubMed ID: 21604935
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

DNA repair gene polymorphisms and tobacco smoking in the risk for colorectal adenomas.

Gao Y,  Hayes RB,  Huang WY,  Caporaso NE,  Burdette L,  Yeager M,  Chanock SJ,  Berndt SI
Carcinogenesis 2011 Jun;32(6):882-7
PubMed ID: 21504893
PMC ID: PMC3106441
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Genome-wide association study of prostate cancer in men of African ancestry identifies a susceptibility locus at 17q21.

Haiman CA,  Chen GK,  Blot WJ,  Strom SS,  Berndt SI,  Kittles RA,  Rybicki BA,  Isaacs WB,  Ingles SA,  Stanford JL,  Diver WR,  Witte JS,  Hsing AW,  Nemesure B,  Rebbeck TR,  Cooney KA,  Xu J,  Kibel AS,  Hu JJ,  John EM,  Gueye SM,  Watya S,  Signorello LB,  Hayes RB,  Wang Z,  Yeboah E,  Tettey Y,  Cai Q,  Kolb S,  Ostrander EA,  Zeigler-Johnson C,  Yamamura Y,  Neslund-Dudas C,  Haslag-Minoff J,  Wu W,  Thomas V,  Allen GO,  Murphy A,  Chang BL,  Zheng SL,  Leske MC,  Wu SY,  Ray AM,  Hennis AJ,  Thun MJ,  Carpten J,  Casey G,  Carter EN,  Duarte ER,  Xia LY,  Sheng X,  Wan P,  Pooler LC,  Cheng I,  Monroe KR,  Schumacher F,  Le Marchand L,  Kolonel LN,  Chanock SJ,  Van Den Berg D,  Stram DO,  Henderson BE
Nat Genet 2011 Jun;43(6):570-3
PubMed ID: 21602798
PMC ID: PMC3102788
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Fine mapping the KLK3 locus on chromosome 19q13.33 associated with prostate cancer susceptibility and PSA levels.

Parikh H,  Wang Z,  Pettigrew KA,  Jia J,  Daugherty S,  Yeager M,  Jacobs KB,  Hutchinson A,  Burdett L,  Cullen M,  Qi L,  Boland J,  Collins I,  Albert TJ,  Vatten LJ,  Hveem K,  Njølstad I,  Cancel-Tassin G,  Cussenot O,  Valeri A,  Virtamo J,  Thun MJ,  Feigelson HS,  Diver WR,  Chatterjee N,  Thomas G,  Albanes D,  Chanock SJ,  Hunter DJ,  Hoover R,  Hayes RB,  Berndt SI,  Sampson J,  Amundadottir L
Hum Genet 2011 Jun;129(6):675-85
PubMed ID: 21318478
PMC ID: PMC3092924
Groups or Programs: Early DetectionPLCO Cancer Screening Trial